Siemens DCA Vantage Analyzer System REF: 06651932 (5075WW) YOM: 2025 (Brand New)

Includes:

- Siemens DCA Vantage Analyzer System REF: 06651932 (5075WW) YOM: 2025 

The Siemens DCA Vantage® Analyzer System (REF: 06651932 / 5075WW, Year of Manufacture: 2025) is a leading point-of-care diagnostic analyzer designed for rapid and accurate measurement of HbA1c, microalbumin, and albumin-to-creatinine ratio (ACR). Manufactured by Siemens Healthineers, the DCA Vantage is trusted worldwide by hospitals, diabetes clinics, physician offices, laboratories, and healthcare providers for its proven analytical performance and fast turnaround times.

Engineered to support effective diabetes management and kidney disease screening, the Siemens DCA Vantage Analyzer delivers laboratory-quality results directly at the point of care, helping clinicians make informed treatment decisions during patient consultations.

Key Features

Rapid HbA1c Testing

Provides accurate glycated hemoglobin (HbA1c) results for effective diabetes diagnosis and long-term glucose monitoring.

Microalbumin & ACR Testing

Supports early detection and monitoring of diabetic nephropathy and kidney disease.

Point-of-Care Diagnostic Platform

Delivers laboratory-quality results within minutes, improving workflow efficiency and patient management.

User-Friendly Touchscreen Interface

Simple operation with intuitive navigation for healthcare professionals.

Compact & Space-Saving Design

Ideal for physician offices, outpatient clinics, diabetes centers, and hospital laboratories.

Trusted Siemens Healthineers Technology

Widely recognized as one of the leading point-of-care analyzers for diabetes management.

Technical Specifications

Manufacturer: Siemens Healthineers

Model: DCA Vantage® Analyzer System

Reference Number: 06651932 (5075WW)

Year of Manufacture: 2025

Device Type: Point-of-Care Diagnostic Analyzer

Testing Parameters: HbA1c, Microalbumin, Albumin-to-Creatinine Ratio (ACR)

Application: Diabetes Monitoring & Kidney Disease Screening

Applications

• Diabetes Clinics
• Endocrinology Departments
• Hospital Laboratories
• Physician Offices
• Point-of-Care Testing Facilities
• Primary Care Practices
• Kidney Disease Screening Programs
• Outpatient Diagnostic Centers

Key Benefits

• Fast and accurate HbA1c results
• Early kidney disease detection capabilities
• Laboratory-quality performance at the point of care
• Improved clinical workflow and patient management
• Compact and easy-to-use design
• Trusted Siemens diagnostic technology
• Ideal for diabetes monitoring programs

Why Choose the Siemens DCA Vantage Analyzer?

The Siemens DCA Vantage Analyzer System (YOM: 2025) is one of the most trusted point-of-care diabetes analyzers available, offering rapid HbA1c testing, microalbumin assessment, and reliable diagnostic performance. It is an ideal solution for healthcare facilities seeking a proven and efficient analyzer for diabetes management and renal disease screening.

The Siemens DCA Vantage Analyzer System is a reliable and efficient tool for clinical laboratories, specifically designed for analyzing blood samples. This system, model number 06651932, is known for its accuracy in HbA1c testing, crucial for monitoring diabetes control. Despite being a used unit, it maintains excellent performance and has been well-preserved since its year of manufacture in 2025. This analyzer features an intuitive interface, making it user-friendly with minimal training required. It provides fast results, typically processing samples within minutes, thereby enhancing workflow efficiency in busy laboratory settings. The compact design of the DCA Vantage allows for seamless integration into a variety of lab environments without taking up unnecessary space. With Siemens' reputation for high-quality medical equipment, this blood analyzer ensures both reliability and precision. It meets industry standards, ensuring consistent and repeatable results, which are essential for patient diagnosis and management. The DCA Vantage Analyzer System presents an excellent choice for labs seeking dependable and swift testing capabilities.